Mymedpharma Limited

POWER SEARCH PRICING

SOLUTIONS

mymedpharma limited Company Information

Company Number

05504955

Next Accounts

Jan 2025

Directors

Mujahid Ali

Tabassam Zabier

Shareholders

mymedpharma holdings ltd

Group Structure

View All

Industry

Other human health activities

Registered Address

mymed house, 95 -97 johnston street, blackburn, lancashire, BB2 1HY

Website

www.mymedpharma.com

mymedpharma limited Estimated Valuation

£17.2k

Pomanda estimates the enterprise value of MYMEDPHARMA LIMITED at £17.2k based on a Turnover of £40.6k and 0.42x industry multiple (adjusted for size and gross margin).

Edit your figures and get a professional valuation report.

Mymedpharma Limited is a dissolved company that was located in blackburn, BB2 1HY with a Companies House number of 05504955. It operated in the other human health activities sector, SIC Code 86900. Founded in July 2005, it's largest shareholder was mymedpharma holdings ltd with a 100% stake. The last turnover for Mymedpharma Limited was estimated at £40.6k.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded Mymedpharma Limited a 1.5 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 4 areas for improvement. Company Health Check FAQs

Health Rating1.5out of 5

1 Strong

2 Regular

4 Weak

Size

annual sales of £40.6k, make it smaller than the average company (£730k)

Growth

There is insufficient data available for this Key Performance Indicator!

EXPORT

Mymedpharma Limited's latest turnover from March 2022 is estimated at £40.6 thousand and the company has net assets of -£15.2 thousand. According to their latest financial statements, Mymedpharma Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Mar 2022	Mar 2021	Mar 2020	Sep 2018	Sep 2017	Sep 2016	Sep 2015	Sep 2014	Sep 2013	Sep 2012	Sep 2011	Sep 2010	Sep 2009
Turnover	40,645	60,378	259,249	786,191	751,973	1,429,892	1,542,231	5,440,323	4,487,064	3,073,354	3,512,761	2,034,207	0
Other Income Or Grants	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost Of Sales	32,336	48,654	203,899	614,525	569,328	1,089,113	1,200,316	4,141,274	3,409,166	2,235,117	2,511,938	1,453,400	0
Gross Profit	8,310	11,725	55,349	171,667	182,645	340,779	341,915	1,299,049	1,077,899	838,237	1,000,823	580,806	0
Admin Expenses	43,504	20,761	20,850	128,178	182,597	378,473	400,001	1,336,765	1,112,017	857,501	1,016,866	440,493	-84,093
Operating Profit	-35,194	-9,036	34,499	43,489	48	-37,694	-58,086	-37,716	-34,118	-19,264	-16,043	140,313	84,093
Interest Payable	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest Receivable	0	35	35	2,226	150	125	1,074	1,506	946	789	728	658	316
Pre-Tax Profit	-35,194	-9,001	34,535	45,715	198	-37,569	-57,012	-36,210	-33,172	-18,475	-15,315	140,971	84,410
Tax	0	0	-6,562	-8,686	-38	0	0	0	0	0	0	-39,472	-23,635
Profit After Tax	-35,194	-9,001	27,973	37,029	160	-37,569	-57,012	-36,210	-33,172	-18,475	-15,315	101,499	60,775
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0
Retained Profit	-35,194	-9,001	27,973	37,029	160	-37,569	-57,012	-36,210	-33,172	-18,475	-15,315	101,499	60,775
Employee Costs	23,868	46,308	113,346	151,313	85,574	388,110	445,190	1,654,009	1,455,666	948,805	1,105,708	610,890	0
Number Of Employees	1	2	5	7	4	19	21	77	68	45	53	30	0
EBITDA*	-28,559	-193	53,741	60,603	48	-10,810	-23,584	-14,049	-13,631	-238	8,273	164,343	84,283

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Mar 2022	Mar 2021	Mar 2020	Sep 2018	Sep 2017	Sep 2016	Sep 2015	Sep 2014	Sep 2013	Sep 2012	Sep 2011	Sep 2010	Sep 2009
Tangible Assets	0	34,825	43,668	61,375	78,489	99,503	126,387	80,427	69,479	65,632	83,468	87,296	760
Intangible Assets	0	0	0	0	0	0	0	0	0	0	0	0	0
Investments & Other	0	0	0	0	0	0	0	0	0	0	0	0	0
Debtors (Due After 1 year)	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Fixed Assets	0	34,825	43,668	61,375	78,489	99,503	126,387	80,427	69,479	65,632	83,468	87,296	760
Stock & work in progress	0	0	0	57,293	69,430	62,100	70,260	64,785	59,250	32,091	9,628	0	0
Trade Debtors	0	0	38,819	150,301	233,784	167,383	185,369	686,606	585,856	412,041	518,410	309,227	112,434
Group Debtors	0	0	0	0	0	0	0	0	0	0	0	0	0
Misc Debtors	0	0	44,429	355,060	0	0	0	0	0	0	0	0	0
Cash	0	119	70,464	529,856	63,795	55,946	44,402	385,205	217,219	161,228	154,424	136,712	126,547
misc current assets	0	0	0	0	0	0	0	0	0	0	0	0	0
total current assets	0	119	153,712	1,092,510	367,009	285,429	300,031	1,136,596	862,325	605,360	682,462	445,939	238,981
total assets	0	34,944	197,380	1,153,885	445,498	384,932	426,418	1,217,023	931,804	670,992	765,930	533,235	239,741
Bank overdraft	0	0	0	0	0	0	0	0	0	0	0	0	0
Bank loan	0	0	0	0	0	0	0	0	0	0	0	0	0
Trade Creditors	15,222	14,972	92,677	372,269	192,872	419,411	410,467	1,144,060	825,409	531,211	605,173	356,117	177,822
Group/Directors Accounts	0	0	0	0	0	0	0	0	0	0	0	0	0
other short term finances	0	0	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0
other current liabilities	0	0	75,730	778,906	286,945	0	0	0	0	0	0	0	0
total current liabilities	15,222	14,972	168,407	1,151,175	479,817	419,411	410,467	1,144,060	825,409	531,211	605,173	356,117	177,822
loans	0	0	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0
Accruals and Deferred Income	0	0	0	0	0	0	0	0	0	0	0	0	0
other liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0
provisions	0	0	0	0	0	0	12,861	12,861	10,083	10,297	12,798	13,844	144
total long term liabilities	0	0	0	0	0	0	12,861	12,861	10,083	10,297	12,798	13,844	144
total liabilities	15,222	14,972	168,407	1,151,175	479,817	419,411	423,328	1,156,921	835,492	541,508	617,971	369,961	177,966
net assets	-15,222	19,972	28,973	2,710	-34,319	-34,479	3,090	60,102	96,312	129,484	147,959	163,274	61,775
total shareholders funds	-15,222	19,972	28,973	2,710	-34,319	-34,479	3,090	60,102	96,312	129,484	147,959	163,274	61,775

	Mar 2022	Mar 2021	Mar 2020	Sep 2018	Sep 2017	Sep 2016	Sep 2015	Sep 2014	Sep 2013	Sep 2012	Sep 2011	Sep 2010	Sep 2009
Operating Activities
Operating Profit	-35,194	-9,036	34,499	43,489	48	-37,694	-58,086	-37,716	-34,118	-19,264	-16,043	140,313	84,093
Depreciation	6,635	8,843	19,242	17,114	0	26,884	34,502	23,667	20,487	19,026	24,316	24,030	190
Amortisation	0	0	0	0	0	0	0	0	0	0	0	0	0
Tax	0	0	-6,562	-8,686	-38	0	0	0	0	0	0	-39,472	-23,635
Stock	0	0	0	-12,137	7,330	-8,160	5,475	5,535	27,159	22,463	9,628	0	0
Debtors	0	-83,248	83,248	271,577	66,401	-17,986	-501,237	100,750	173,815	-106,369	209,183	196,793	112,434
Creditors	250	-77,705	92,677	179,397	-226,539	8,944	-733,593	318,651	294,198	-73,962	249,056	178,295	177,822
Accruals and Deferred Income	0	-75,730	75,730	491,961	286,945	0	0	0	0	0	0	0	0
Deferred Taxes & Provisions	0	0	0	0	0	-12,861	0	2,778	-214	-2,501	-1,046	13,700	144
Cash flow from operations	-28,309	-70,380	132,338	463,835	-13,315	11,419	-261,415	201,095	79,379	7,205	37,472	120,073	126,180
Investing Activities
capital expenditure	28,190	0	-62,910	0	21,014	0	-80,462	-34,615	-24,334	-1,190	-20,488	-110,566	-950
Change in Investments	0	0	0	0	0	0	0	0	0	0	0	0	0
cash flow from investments	28,190	0	-62,910	0	21,014	0	-80,462	-34,615	-24,334	-1,190	-20,488	-110,566	-950
Financing Activities
Bank loans	0	0	0	0	0	0	0	0	0	0	0	0	0
Group/Directors Accounts	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Short Term Loans	0	0	0	0	0	0	0	0	0	0	0	0	0
Long term loans	0	0	0	0	0	0	0	0	0	0	0	0	0
Hire Purchase and Lease Commitments	0	0	0	0	0	0	0	0	0	0	0	0	0
other long term liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0
share issue	0	0	1,000	0	0	0	0	0	0	0	0	0	1,000
interest	0	35	35	2,226	150	125	1,074	1,506	946	789	728	658	316
cash flow from financing	0	35	1,035	2,226	150	125	1,074	1,506	946	789	728	658	1,316
cash and cash equivalents
cash	-119	-70,345	70,464	466,061	7,849	11,544	-340,803	167,986	55,991	6,804	17,712	10,165	126,547
overdraft	0	0	0	0	0	0	0	0	0	0	0	0	0
change in cash	-119	-70,345	70,464	466,061	7,849	11,544	-340,803	167,986	55,991	6,804	17,712	10,165	126,547

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for mymedpharma limited. Get real-time insights into mymedpharma limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for mymedpharma limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other undefined companies, companies in BB2 area or any other competitors across 12 key performance metrics.

MYMEDPHARMA LIMITED group structure

Mymedpharma Limited has no subsidiary companies.

Ultimate parent company

MYMEDPHARMA HOLDINGS LTD

11632410

1 parent

MYMEDPHARMA LIMITED

05504955

MYMEDPHARMA LIMITED Shareholders

mymedpharma holdings ltd

100%

Mymedpharma Limited currently has 2 directors. The longest serving directors include Mr Mujahid Ali (Jul 2005) and Mr Tabassam Zabier (Sep 2009).

officer	country	age	start	end	role
Mr Mujahid Ali	England	45 years	Jul 2005	-	Director
Mr Tabassam Zabier	United Kingdom	46 years	Sep 2009	-	Director

P&L

March 2022

turnover

40.6k

-33%

operating profit

-35.2k

gross margin

20.5%

+5.28%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

March 2022

net assets

-15.2k

-1.76%

total assets

-1%

cash

-1%

net assets

Total assets minus all liabilities

Similar Companies

acorn polymers (u.k.) ltd

3.5

shine therapy services limited

sanroig limited

at therapy limited

higherland ltd

2.5

company number

05504955

Type

Private limited with Share Capital

industry

86900 - Other human health activities

incorporation date

July 2005

ultimate parent company

MYMEDPHARMA HOLDINGS LTD

previous names

N/A

address

mymed house, 95 -97 johnston street, blackburn, lancashire, BB2 1HY

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to mymedpharma limited.

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for MYMEDPHARMA LIMITED. This can take several minutes, an email will notify you when this has completed.

mymedpharma limited Company Information

mymedpharma limited Estimated Valuation

mymedpharma limited Estimated Valuation

mymedpharma limited Estimated Valuation

Mymedpharma Limited Overview

Mymedpharma Limited Health Check

MYMEDPHARMA LIMITED financials

mymedpharma limited Credit Report and Business Information

Mymedpharma Limited Competitor Analysis

mymedpharma limited Ownership

mymedpharma limited directors

mymedpharma limited company details

mymedpharma limited Charges & Mortgages

mymedpharma limited Capital Raised & Share Issues BETA

mymedpharma limited Companies House Filings - See Documents